FDA Approves Oral Wegovy: Novo Nordisk Launches Groundbreaking Weight Loss Pill Offering New Hope for Obesity Management cover art

FDA Approves Oral Wegovy: Novo Nordisk Launches Groundbreaking Weight Loss Pill Offering New Hope for Obesity Management

FDA Approves Oral Wegovy: Novo Nordisk Launches Groundbreaking Weight Loss Pill Offering New Hope for Obesity Management

Listen for free

View show details

About this listen

 # Wegovy Pill: FDA Approves First Oral GLP-1 Therapy for Weight Management - Global Health Watch Podcast

Discover the groundbreaking FDA approval of Novo Nordisk's Wegovy pill, the first oral GLP-1 treatment for chronic weight management. Host Alexandra Reeves explores how this once-daily pill matches the impressive 16.6% weight loss results of injectable Wegovy without needles or refrigeration. Learn about the OASIS 4 trial results, pricing strategies, competitive landscape with Eli Lilly, and California Medi-Cal coverage changes. This episode unpacks how this convenient oral semaglutide option could revolutionize obesity treatment for millions who avoided injections, with insights on effectiveness, side effects, and real-world impact for those managing obesity and related health conditions.

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

This content was created in partnership and with the help of Artificial Intelligence AI
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.